Nephrology

Dr. Öğr. Üyesi Banu Erkalma

Doctor and researcher Medicana Ataköy İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.

  • Böbrek nakli ve ilişkili hastalıklar
  • Kronik böbrek yetmezliği
  • Glomerülonefritler
  • Hipertansiyon
  • Diyabet
  • Böbreğin kistik hastalıkları
  • Böbreğin genetik hastalıkları
  • Böbreğin damarsal hastalıkları
  • Diyaliz
  • İdrar yolu hastalıkları
  • İdrarda protein kaçakları ve idrarda kanamalar

CV

Education and experience

From source

Experience

  • 2012-2014Diyarbakır Eğitim Araştırma Hastanesi İç Hastalıklarımedicana.com.tr
  • 2017-2022İstanbul Medeniyet Üniversitesi Prof. Dr. Süleyman Yalçın Şehir Hastanesimedicana.com.tr
  • 2022-2023Medipol Bahçelievler Hastanesimedicana.com.tr
  • 2023-2024Acıbadem International / Acıbadem Fulya Hastanesimedicana.com.tr
  • 2024-2026Biruni Üniversite Hastanesi Nefroloji / Organ Naklimedicana.com.tr

Education

  • 2006İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesimedicana.com.tr
  • 2012İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalımedicana.com.tr
  • 2017İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Nefroloji Bilim Dalımedicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNephrologymedicana.com.trFrom source
  • InstitutionMedicana Ataköymedicana.com.trFrom source
  • Publications27 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:26https://www.medicana.com.tr/hekim-detay/27849/banu-erkalmamedicana.com.tr

Scientific work

Publications

27 publications

  1. A1: Meric K, Bakal N, Şenateş E, Aydın S, Kılıçoğlu ZG, Bahadır Ülger FE, Yencilek E, Erkalma Şenateş B, Şimşek M. Comparison of a 4-Day versus 2-Day Low Fiber Diet Regimen in Barium Tagging CT Colonography in Incomplete Colonoscopy Patients. Gastroenterol Res Pract. 2015;2015:609150. doi: 10.1155/2015/609150.

    Source: medicana.com.tr profile page

  2. A2: RELATIONSHIP BETWEEN SERUM LIPIDS AND COLON POLYPS: A PILOT STUDY KADIR KAYATAŞ, ÖZHAN KAYA, EBUBEKIR ŞENATEŞ, ATAKAN YEŞIL, BANU ERKALMA ŞENATEŞ, EZGI ERSOY YEŞIL, ERDAL BELEN, AKIN DAYAN, REFIK DEMIRTUNÇ. Acta Medica Mediterranea, 2014, 30: 57.

    Source: medicana.com.tr profile page

  3. A3: Ebubekir Şenateş, Abdullah Doğan, Banu Erkalma Şenateş, Erdal Bodakçı, Muhammet Bekçibaşı. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma. Infez Med. 2014;22(4):313-6.

    Source: medicana.com.tr profile page

  4. A4: Banu Erkalma Şenateş, Abdullah Doğan, Ebubekir Şenateş. Symptomatic hypocalcaemia following intravenous administration of zoledronic acid in a female patient with osteoporosis. Acta Medica Mediterranea, 2015, 31: 895.

    Source: medicana.com.tr profile page

  5. A5: Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman Ot, Erkalma Şenateş B, Tuncer I. Circulating Resistin is Elevated in Patients with Non-Alcoholic Fatty Liver Disease and is Associated With Steatosis, Portal İnflammation, İnsulin Resistance And Nonalcoholic Steatohepatitis Scores. Minerva Med. 2012 Oct;103(5):369-76.

    Source: medicana.com.tr profile page

  6. A6: Yalin SF, Gulcicek S, Avci S, Erkalma Senates B, Altiparmak MR, Trabulus S, Alagoz S, Yavuzer H, Doventas A, Seyahi N. Single-frequency and multi-frequency bioimpedance analysis: What is the difference? Nephrology (Carlton). 2018;23(5):438-445. doi: 10.1111/nep.13042.

    Source: medicana.com.tr profile page

  7. A7: Amyloid A Amyloidosis After Renal Transplantation: An Important Cause of Mortality. I, Sarihan I, Caliskan Y, Mirioglu S, Ozluk Y, Senates B, Seyahi N, Basturk T, Yildiz A, Kilicaslan Sever 10.1097/TP.0000000000003043. MS.Transplantation. 2020;104(8):1703-1711. doi:

    Source: medicana.com.tr profile page

  8. A8: Fabry Disease Prevalence in Renal Replacement Therapy in Turkey. Yalın SF, Eren N, Sinangil A, Yilmaz VT, Tatar E, Ucar AR, Sevinc M, Can Ö, Gurkan A, Arik N, Alisir Ecder S, Uyar M, Yasar M, Gulcicek S, Mese M, Dheir H, Cakir U, Köksal Cevher Ş, Turkmen K, Guven B, Guven Taymez D, Erkalma Senates B, Ecder T, Kocak H, Uslu A, Demir E, Basturk T, Ogutmen MB, Kinalp C, Dursun B, Bicik Bahcebasi Z, Sipahi S, Dede F, Oruc M, Caliskan Y, Genc A, Yelken B, Altıparmak MR, Turkmen A, Seyahi N. Nephron. 2019;142(1):26-33. doi: 10.1159/000496620. Epub 2019 Feb 8. PMID: 30739116.

    Source: medicana.com.tr profile page

  9. A9: Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Vural Keskinler M, Mutlu HH, Sirin A, Erkalma Senates B, Colak Y, Tuncer I, Oguz A. Metab Syndr Relat Disord. 2021 Feb;19(1):26-31. doi: 10.1089/met.2020.0054. Epub 2020 Sep 7. PMID: 32898457.

    Source: medicana.com.tr profile page

  10. A10: Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target. Colak Y, Hasan B, Erkalma B, Tandon K, Zervos X, Menzo EL, Erim T. Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101710. doi: 10.1016/j.clinre.2021.101710. Epub 2021 Apr 27.

    Source: medicana.com.tr profile page

View all 27 publications